Mechanism of acridine-based telomerase inhibition and telomere shortening

被引:120
作者
Gunaratnam, Mekala
Greciano, Olga
Martins, Cristina
Reszka, Anthony P.
Schultes, Christoph M.
Morjani, Hamid
Riou, Jean-Francois
Neidle, Stephen
机构
[1] Univ London, Sch Pharm, CRUK Biomol Struct Grp, London WC1N 1AX, England
[2] Univ Reims, UFR Pharm, JE 2428, Lab Onco Pharmacol, F-51096 Reims, France
关键词
G-quadruplex ligands; telomerase; telomere targeting;
D O I
10.1016/j.bcp.2007.06.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The trisubstituted acridine compound BRACO-19 has been developed as a ligand for stabilising G-quadruplex structures. It is shown here that BRACO-19 produces short- and long-term growth arrest in cancer cell lines, and is significantly less potent in a normal cell line. BRACO-19 reduces telomerase activity and long-term telomere length attrition is observed. It is also shown that BRACO-19 binds to telomeric single-stranded overhang DNA, consistent with quadruplex formation, and the single-stranded protein hPOT1 has been shown to be displaced from the overhang in vitro and in cellular experiments. It is concluded that the cellular activity of BRACO-19 can be ascribed both to the uncapping of 3' telomere ends and to telomere shortening that may preferentially affect cells with short telomeres. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:679 / 689
页数:11
相关论文
共 68 条
[1]   The structure and function of telomerase reverse transcriptase [J].
Autexier, Chantal ;
Lue, Neal F. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :493-517
[2]   Switching and signaling at the telomere [J].
Blackburn, EH .
CELL, 2001, 106 (06) :661-673
[3]   Transformation of human and murine fibroblasts without viral oncoproteins [J].
Boehm, JS ;
Hession, MT ;
Bulmer, SE ;
Hahn, WC .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (15) :6464-6474
[4]   Telomerase and the maintenance of chromosome ends [J].
Bryan, TM ;
Cech, TR .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (03) :318-324
[5]   The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function [J].
Burger, AM ;
Dai, FP ;
Schultes, CM ;
Reszka, AP ;
Moore, MJ ;
Double, JA ;
Neidle, S .
CANCER RESEARCH, 2005, 65 (04) :1489-1496
[6]   Telomerase-based immunotherapy of cancer [J].
Carpenter, Erica L. ;
Vonderheide, Robert H. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (10) :1031-1039
[7]   Antitumor polycyclic acridines. 17. Synthesis and pharmaceutical profiles of pentacyclic acridinium salts designed to destabilize telomeric integrity [J].
Cookson, JC ;
Heald, RA ;
Stevens, MFG .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (23) :7198-7207
[8]   Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl] acridinium methosulfate (RHPS4) in vitro:: Activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents [J].
Cookson, JC ;
Dai, FP ;
Smith, V ;
Heald, RA ;
Laughton, CA ;
Stevens, MFG ;
Burger, AM .
MOLECULAR PHARMACOLOGY, 2005, 68 (06) :1551-1558
[9]  
d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
[10]   Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532 [J].
El-Daly, H ;
Kull, M ;
Zimmermann, S ;
Pantic, M ;
Waller, CF ;
Martens, UM .
BLOOD, 2005, 105 (04) :1742-1749